Table 3 Comparison between patients with and without late RVF

 DCM, n(%)

82 (63%)

7 (44%)

0.38 (0.13–1.06)

0.06

 dHCM, n(%)

15 (11%)

7 (44%)

5.11 (1.79–14.2)

0.0032*

2.89 (0.87–9.15)

0.08

 ICM, n(%)

15 (11%)

0 (0%)

–

0.07

 pacing device, n(%)

67 (52%)

13 (81%)

3.77 (1.21–16.5)

0.02*

3.75 (1.11–17.8)

0.03*

 (except for TR worsening after RVF)

6 (5%)

0 (0%)

–

0.28

 LVDd (mm)

70.4 ± 12.1

63.3 ± 15.7

0.95 (0.91–0.99)

0.01*

0.87 (0.69–1.08)

0.20

 LVDs (mm)

65.0 ± 12.8

57.0 ± 17.8

0.96 (0.92–0.99)

0.01*

1.10 (0.89–1.36)

0.38

 LVEF (%)

20.1 ± 8.1

25.6 ± 11.0

1.06 (1.01–1.11)

0.02*

1.03 (0.94–1.12)

0.55

 RVDd (mm)

39.8 ± 10.1

41.0 ± 9.0

1.01 (0.96–1.07)

0.62

 TAPSE (mm/s)

14.5 ± 4.7

12.7 ± 4.3

0.92 (0.80–1.04)

0.19

 TRPG (mmHg)

32.0 ± 14.0

27.6 ± 13.4

0.96 (0.91–1.00)

0.07

 PAP systolic (mmHg)

40.0 ± 13.3

39.6 ± 15.3

0.98 (0.95–1.02)

0.39

 PAP diastolic (mmHg)

19.8 ± 7.9

19.0 ± 8.9

0.97 (0.91–1.03)

0.30

 PAP mean (mmHg)

27.8 ± 9.6

27.6 ± 11.1

0.98 (0.93–1.03)

0.39

 PCWP (mmHg)

20.1 ± 8.3

19.8 ± 10.5

0.97 (0.92–1.03)

0.37

 RAP (mmHg)

7.6 ± 4.8

9.6 ± 4.8

1.07 (0.97–1.17)

0.18

 CI(L/min/m2)

2.25 ± 0.80

2.26 ± 0.52

1.09 (0.56–1.74)

0.78

 RAP/PCWP

0.39 ± 0.30

0.50 ± 0.22

2.55 (0.61–6.47)

0.17

 PAPi

2.86 (0.55–17)

2.17 (0.81–16)

0.93 (0.74–1.10)

0.47

 RVSWI (mmHg×ml/m2)

537 ± 281

533 ± 277

1.00 (1.00–1.00)

0.71

 BUN (mg/dl)

19.7 ± 12.5

24.1 ± 11.4

1.02 (0.99–1.05)

0.17

 Cr (mg/dl)

1.04 ± 0.49

1.18 ± 0.47

1.50 (0.57–3.12)

0.38

 Ccr (ml/min/m2)

72.9 ± 35.3

56.7 ± 23.4

0.98 (0.96–1.00)

0.08

 T-Bil (mg/dl)

1.07 ± 0.77

1.02 ± 0.51

0.94 (0.38–1.76)

0.87

 BNP (pg/μl)

388 (30.8–4206)

561 (44–3022)

1.00 (1.00–1.00)

0.50